HighteawithIntrepid HT: like your buddy Edrose, you still don’t get it. The success of Prometic will not be measured in days or months, success will be measured when Prometic gets their two franchise drugs, Ryplazim and PBI-4050, selling in the marketplace. Until then, Prometic is just another fledgling high risk biotech startup (pre FDA drug approval).
I’m not sure why guys like you invest “long” in speculative stocks like PLI when you appear to lack the basic and elementary knowledge of how these high risk biotech companies work. I say this because of your repetitive “cash burn” comments.
A “shelf offering” was put into place in the company’s charter a few months ago for a reason, it’s a very quick way to raise a large sum of money, and with the remarkable phase 2 Alstrom and phase 2 IPF trial results Prometic would have no problem raising enough cash to fund an entire year of operations imo. Any dilution issue will be addressed through their expected future reverse split.
So no, I will not play your “date” guessing games.
The EOY (end of year) 2020 is my target date. As I’ve stated many times —> by EOY 2020 Ryplazim will be selling in the marketplace and 4050 will be selling to Alstrom patients in the U.K. That’s when I will begin to measure the value of Prometic.
With a stock like PLI I choose to accumulate as much stock as I can while the price is under $1 and hold until my 2020 date. Another way to make money is to maybe short or day trade PLI for the next 18 months imo, chose your own poison for this high risk stock,
but your claims Of being a “conscript” is lame and weak. Sell and move on if you’re so unhappy in life with PLI. Sent from my iPad